82 related articles for article (PubMed ID: 8859002)
41. Furosemide inhibits bradykinin-induced contraction of human bronchi: role of thromboxane A2 receptor antagonism.
Molimard M; Naline E; Hirsch A; Advenier C
Eur J Pharmacol; 1995 May; 278(3):253-6. PubMed ID: 7589163
[TBL] [Abstract][Full Text] [Related]
42. Antagonism of thromboxane receptor induced contractions in isolated human groin lymphatics.
Sjöberg T; Andersson KE; Norgren L; Steen S
Lymphology; 1989 Sep; 22(3):135-40. PubMed ID: 2532276
[TBL] [Abstract][Full Text] [Related]
43. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K
J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950
[TBL] [Abstract][Full Text] [Related]
44. Thromboxane A2 receptors in equine monocytes: identification of a new subclass of TXA2 receptors.
Simmons TR; Cook JA; Moore JN; Halushka PV
J Leukoc Biol; 1993 Feb; 53(2):173-8. PubMed ID: 8383167
[TBL] [Abstract][Full Text] [Related]
45. A comparative study of thromboxane (TP) receptor mimetics and antagonists on isolated human umbilical artery and myometrium.
Abbas F; Amin Z; Burk RM; Krauss AH; Marshall K; Senior J; Woodward DF
Adv Exp Med Biol; 1997; 407():219-30. PubMed ID: 9321956
[No Abstract] [Full Text] [Related]
46. Evidence for a dilator function of 8-iso prostaglandin F2 alpha in rat pulmonary artery.
Jourdan KB; Evans TW; Curzen NP; Mitchell JA
Br J Pharmacol; 1997 Apr; 120(7):1280-5. PubMed ID: 9105703
[TBL] [Abstract][Full Text] [Related]
47. The human thromboxane A2 receptor alpha isoform (TP alpha) functionally couples to the G proteins Gq and G11 in vivo and is activated by the isoprostane 8-epi prostaglandin F2 alpha.
Kinsella BT; O'Mahony DJ; Fitzgerald GA
J Pharmacol Exp Ther; 1997 May; 281(2):957-64. PubMed ID: 9152406
[TBL] [Abstract][Full Text] [Related]
48. Pharmacological characterization of prostanoid receptors mediating vasoconstriction in human umbilical vein.
Daray FM; Minvielle AI; Puppo S; Rothlin RP
Br J Pharmacol; 2003 Aug; 139(8):1409-16. PubMed ID: 12922927
[TBL] [Abstract][Full Text] [Related]
49. A proposed common spatial pharmacophore and the corresponding active conformations of some TxA2 receptor antagonists.
Jin B; Hopfinger AJ
J Chem Inf Comput Sci; 1994; 34(4):1014-21. PubMed ID: 7929664
[TBL] [Abstract][Full Text] [Related]
50. The use of synthetic thromboxane A2 (TXA2-S) and a new class of thromboxane antagonists, indole-2-propanoic acids to characterize the thromboxane receptor.
Gillard JW; Morton HE; Fortin R; Yoakim C; Girard Y; Lord A; Ethier D; Leveille C; Letts G; Evans J
Prog Clin Biol Res; 1989; 301():579-83. PubMed ID: 2529557
[No Abstract] [Full Text] [Related]
51. Prostanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins.
Walch L; de Montpreville V; Brink C; Norel X
Br J Pharmacol; 2001 Dec; 134(8):1671-8. PubMed ID: 11739243
[TBL] [Abstract][Full Text] [Related]
52. Pregnancy enhances the pressor response to thromboxane analogues in rabbits.
Losonczy G; Singh JP; Schoenl M; Mucha I; Venuto RC
Am J Physiol; 1995 Sep; 269(3 Pt 2):R720-5. PubMed ID: 7573575
[TBL] [Abstract][Full Text] [Related]
53. Losartan prevents thromboxane A2/prostanoid (TP) receptor mediated increase in microvascular permeability in the rat.
Valentin JP; Jover B; Maffre M; Bertolino F; Bessac AM; John GW
Am J Hypertens; 1997 Sep; 10(9 Pt 1):1058-63. PubMed ID: 9324114
[TBL] [Abstract][Full Text] [Related]
54. Evidence for partial agonist properties of daltroban (BM 13,505) at TP receptors in the anaesthetized open-chest rat.
Bertolino F; Valentin JP; Patoiseau JF; Rieu JP; Colpaert FC; John GW
Naunyn Schmiedebergs Arch Pharmacol; 1997 Oct; 356(4):462-6. PubMed ID: 9349632
[TBL] [Abstract][Full Text] [Related]
55. The bovine thromboxane A2 receptor: molecular cloning, expression, and functional characterization.
Muck S; Weber AA; Meyer-Kirchrath J; Schrör K
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):10-6. PubMed ID: 9459567
[TBL] [Abstract][Full Text] [Related]
56. Thromboxane receptor signalling in human myometrial cells.
Moore F; Asbóth G; López BA
Prostaglandins Other Lipid Mediat; 2002 Jan; 67(1):31-47. PubMed ID: 11789896
[TBL] [Abstract][Full Text] [Related]
57. Functional characterization of the prostanoid DP receptor in human myometrium.
Fernandes B; Crankshaw D
Eur J Pharmacol; 1995 Sep; 283(1-3):73-81. PubMed ID: 7498323
[TBL] [Abstract][Full Text] [Related]
58. Distribution of binding sites for thromboxane A2 in the mouse kidney.
Mannon RB; Coffman TM; Mannon PJ
Am J Physiol; 1996 Dec; 271(6 Pt 2):F1131-8. PubMed ID: 8997386
[TBL] [Abstract][Full Text] [Related]
59. Thromboxane receptor density is increased in human cardiovascular disease with evidence for inhibition at therapeutic concentrations by the AT(1) receptor antagonist losartan.
Katugampola SD; Davenport AP
Br J Pharmacol; 2001 Dec; 134(7):1385-92. PubMed ID: 11724743
[TBL] [Abstract][Full Text] [Related]
60. Vasoconstrictor effects of 8-iso-prostaglandin E2 and 8-iso-prostaglandin F(2alpha) on human umbilical vein.
Daray FM; Minvielle AI; Puppo S; Rothlin RP
Eur J Pharmacol; 2004 Sep; 499(1-2):189-95. PubMed ID: 15363966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]